Impact Capital Partners’s Pfizer PFE Stock Holding History

Impact Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$293K	Sell	12,174 -552	-4%	-$14.4K	0.08%	218
2026 Q1	$357K	Buy	12,726 +970	+8%	+$25.8K	0.11%	184
2025 Q4	$293K	Sell	11,756 -1,177	-9%	-$29.7K	0.09%	223
2025 Q3	$330K	Buy	12,933 +629	+5%	+$15.5K	0.1%	195
2025 Q2	$298K	Sell	12,304 -1,382	-10%	-$32.2K	0.1%	204
2025 Q1	$347K	Buy	13,686 +2,864	+26%	+$74.9K	0.13%	183
2024 Q4	$287K	Buy	+10,822	New	+$294K	0.1%	209

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Impact Capital Partners's PFE Position: Q2 2026 in Review

Impact Capital Partners reduced its Pfizer (PFE) stake by 4.3% in Q2 2026, selling an estimated $14.4K and leaving 12,174 shares worth $293K. The position accounts for 0.08% of the portfolio, ranked #218.

Impact Capital Partners first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $357K in Q1 2026. 699 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Impact Capital Partners held 12,174 shares of Pfizer worth $293K as of Q2 2026.
Impact Capital Partners sold 552 Pfizer shares in Q2 2026, an estimated $14.4K.
Pfizer made up 0.08% of Impact Capital Partners's portfolio in Q2 2026, its #218 holding.
Impact Capital Partners first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Impact Capital Partners's Pfizer position peaked at $357K in Q1 2026.
699 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Impact Capital Partners's 13F filing for Q2 2026, filed 14 Jul 2026.